- Home
- BLMZ vs NLSP Comparison
BLMZ vs NLSP Comparison
Compare BLMZ & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMZ
- NLSP
- Stock Information
- Founded
- BLMZ 2017
- NLSP 2015
- Country
- BLMZ Japan
- NLSP Switzerland
- Employees
- BLMZ N/A
- NLSP N/A
- Industry
- BLMZ
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- BLMZ
- NLSP Health Care
- Exchange
- BLMZ NYSE
- NLSP Nasdaq
- Market Cap
- BLMZ 5.3M
- NLSP 6.2M
- IPO Year
- BLMZ 2024
- NLSP 2021
- Fundamental
- Price
- BLMZ $0.41
- NLSP $1.95
- Analyst Decision
- BLMZ
- NLSP
- Analyst Count
- BLMZ 0
- NLSP 0
- Target Price
- BLMZ N/A
- NLSP N/A
- AVG Volume (30 Days)
- BLMZ 156.3K
- NLSP 6.1M
- Earning Date
- BLMZ 02-15-2025
- NLSP 10-18-2024
- Dividend Yield
- BLMZ N/A
- NLSP N/A
- EPS Growth
- BLMZ N/A
- NLSP N/A
- EPS
- BLMZ N/A
- NLSP N/A
- Revenue
- BLMZ $1,535,822.00
- NLSP N/A
- Revenue This Year
- BLMZ N/A
- NLSP N/A
- Revenue Next Year
- BLMZ N/A
- NLSP N/A
- P/E Ratio
- BLMZ N/A
- NLSP N/A
- Revenue Growth
- BLMZ 71.48
- NLSP N/A
- 52 Week Low
- BLMZ $0.33
- NLSP $1.71
- 52 Week High
- BLMZ $4.30
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- BLMZ N/A
- NLSP 44.06
- Support Level
- BLMZ N/A
- NLSP $2.14
- Resistance Level
- BLMZ N/A
- NLSP $2.34
- Average True Range (ATR)
- BLMZ 0.00
- NLSP 0.24
- MACD
- BLMZ 0.00
- NLSP -0.00
- Stochastic Oscillator
- BLMZ 0.00
- NLSP 12.07
About BLMZ BLOOMZ INC
BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.